Sequenta's Series A Round

Sequenta raised a round of funding on July 15, 2009. Investors include Mohr Davidow Ventures.

Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…

Articles about Sequenta's Series A Round: